Surgery Partners, Inc. reaffirmed earnings guidance for the year ended December 31, 2017. The company reaffirmed guidance at the upper half of the range for 2017 revenue of $1.30 billion to $1.33 billion and Adjusted EBITDA of $178 million to $185 million, which includes the normalization for the impact of hurricanes and the reserve adjustment.